Automated Innovations and Rising Disease Burdens Fueling Growth
The global dialysis machines market is on the brink of a revolutionary surge, poised to reach a staggering valuation of US$ 24 billion by the end of 2031, as per the latest market analysis. With current revenues standing at US$ 18.5 billion in 2024, the market is estimated to advance at a CAGR of 4.0% over the forecast period.
In tandem with these achievements, PD methodologies have also witnessed remarkable advancements, largely due to the development of specialized machines and cyclers. Initially, PD involved manual delivery and drainage of fluid from the peritoneal cavity, relying on gravity to fill bottles or containers.
However, the introduction of automatic or semi-automatic equipment has revolutionized PD treatment, enabling sufficient therapy administration even during nighttime without requiring direct involvement from the patient or a caregiver.
These advancements have effectively addressed the challenge of therapeutic delivery. Yet, other issues such as complications and prescription adherence remained. To tackle these concerns, magnetic cards containing therapy information were utilized, requiring patients to present them during subsequent hospital sessions.
Today, the introduction of innovative cyclers like the "HOMECHOICE CLARIA," equipped with SHARESOURCE software and bidirectional connection protocols, has overcome these limitations. This technology allows for full remote patient management (RPM), significantly improving prescription adherence and patient outcomes.
For patients undergoing long-term PD, RPM has proven to offer numerous benefits, including enhanced overall survival rates, reduced comorbidities, and lowered costs. These advancements signify a significant step forward in improving the efficacy and accessibility of PD treatment for patients worldwide.
This product will be delivered within 1-3 business days.
The global dialysis machines market is on the brink of a revolutionary surge, poised to reach a staggering valuation of US$ 24 billion by the end of 2031, as per the latest market analysis. With current revenues standing at US$ 18.5 billion in 2024, the market is estimated to advance at a CAGR of 4.0% over the forecast period.
Automation Driving Progress:
Over the years, significant progress has been made in enhancing peritoneal dialysis (PD) techniques. These advancements include improvements in fluid quality, enhanced reliability of catheters and connectors, and a deeper understanding of the peritoneal membrane's role in the mass transfer separation process typical of PD.In tandem with these achievements, PD methodologies have also witnessed remarkable advancements, largely due to the development of specialized machines and cyclers. Initially, PD involved manual delivery and drainage of fluid from the peritoneal cavity, relying on gravity to fill bottles or containers.
However, the introduction of automatic or semi-automatic equipment has revolutionized PD treatment, enabling sufficient therapy administration even during nighttime without requiring direct involvement from the patient or a caregiver.
These advancements have effectively addressed the challenge of therapeutic delivery. Yet, other issues such as complications and prescription adherence remained. To tackle these concerns, magnetic cards containing therapy information were utilized, requiring patients to present them during subsequent hospital sessions.
Today, the introduction of innovative cyclers like the "HOMECHOICE CLARIA," equipped with SHARESOURCE software and bidirectional connection protocols, has overcome these limitations. This technology allows for full remote patient management (RPM), significantly improving prescription adherence and patient outcomes.
For patients undergoing long-term PD, RPM has proven to offer numerous benefits, including enhanced overall survival rates, reduced comorbidities, and lowered costs. These advancements signify a significant step forward in improving the efficacy and accessibility of PD treatment for patients worldwide.
Overcoming Limitations:
Despite its efficacy, dialysis treatment faces significant challenges. The high cost of chronic kidney disease (CKD), limited physiological replacement, environmental impact, and adverse effects on quality of life present formidable obstacles. Moreover, the intermittent nature of dialysis application contributes to fluctuating electrolyte and fluid levels, impacting patient prognosis. However, with ongoing research and development, the industry is actively addressing these limitations to provide more sustainable and patient-centric solutions.Country-specific Trends:
U.S. Dominates North American Market:
The United States leads the North American market, driven by a burgeoning diabetic population and increasing prevalence of lifestyle-related diseases. Federal reimbursement programs and rising healthcare expenditures further bolster demand for dialysis machines, underlining the country's pivotal role in regional market expansion.Germany's Lucrative Landscape:
Germany emerges as a lucrative market in Europe, propelled by favorable reimbursement policies and a significant geriatric population. With a high incidence of renal failure, the nation relies on peritoneal dialysis and hemodialysis to manage end-stage renal disease (ESRD). The growing elderly demographic further fuels market growth, promising lucrative opportunities for manufacturers.China's Emerging Prominence:
China commands the East Asian market, driven by a rising incidence of end-stage renal disease and increasing adoption of dialysis treatments. The proliferation of dialysis centers and the preference for non-invasive treatments over kidney transplants contribute to the country's growing demand for dialysis machines, positioning it as a prominent player in the global market landscape.Competition Analysis:
Leading manufacturers such as Medtronic Plc, B. Braun Melsungen AG, and Fresenius Medical Care are intensifying their efforts to enhance market share through the development of affordable and innovative dialysis machines. Emerging companies and established market leaders alike are focusing on cost-effective solutions to meet consumer demand and drive industry growth.Key Companies Profiled in the market include:
- Medtronic Plc
- Teleflex, Inc.
- B. Braun Melsungen AG
- C. R. Bard (Becton, Dickinson & Company)
- Asahi Kasei Corporation
- Baxter International, Inc.
- Fresenius Medical Care (Fresenius SE & Co. KGaA)
- Nipro Corporation
- Toray Medical Co. Ltd. [Toray Industries, Inc.]
- Allmed Medical Care
- AngioDynamics
- AWAK Technologies
- Dialife S.A.
- ESCO Medicon
- Quanta Dialysis Technologies
- Hemoclean Co., Ltd.
- Nikkiso Co., Ltd.
- Outset Medical, Inc.
Key Segments Covered in Dialysis Machines Industry Research
Product:
- Hemodialysis Devices
- Hemodialysis Machines
- Dialyzers and Filters
- Vascular access devices
- Peritoneal Dialysis Devices
- Automated peritoneal dialysis Machine
- Dialyzers and Filters
- Vascular access devices
- CRRT
- Consumables
Indication:
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- End Stage Renal Disease (ESRD)
End User:
- Hospitals
- Clinics & Dialysis Centers
- Ambulatory Surgical Centers
- Home Care Setting
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Production Output and Trade Statistics, 2018 - 2023
4. Price Analysis, 2018 - 2023
5. Global Dialysis Machines Market Outlook, 2018 - 2031
6. North America Dialysis Machines Market Outlook, 2018 - 2031
7. Europe Dialysis Machines Market Outlook, 2018 - 2031
8. Asia Pacific Dialysis Machines Market Outlook, 2018 - 2031
9. Latin America Dialysis Machines Market Outlook, 2018 - 2031
10. Middle East & Africa Dialysis Machines Market Outlook, 2018 - 2031
11. Competitive Landscape
12. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic Plc
- Teleflex, Inc.
- B. Braun Melsungen AG
- C. R. Bard (Becton, Dickinson & Company)
- Asahi Kasei Corporation
- Baxter International, Inc.
- Fresenius Medical Care (Fresenius SE & Co. KGaA)
- Nipro Corporation
- Toray Medical Co. Ltd. [Toray Industries, Inc.]
- Allmed Medical Care
- AngioDynamics
- AWAK Technologies
- Dialife S.A.
- ESCO Medicon
- Quanta Dialysis Technologies
- Hemoclean Co., Ltd.
- Nikkiso Co., Ltd.
- Outset Medical, Inc.
Methodology
LOADING...